Lisa Baldwin

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

EVIDENCE FOR ACTIVELY ACQUIRED TOLERANCE TO Rh ANTIGENS

Ray Owen, Harold R. Wood, Alvin G. Foord et al. · Proceedings of the National Academy of Sciences · 1954 · 133 citations · Full text

Life Sciences, Immunology, Poultry Science +9

Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2

Ana I. Cubas-Atienzar, Konstantina Kontogianni, Thomas Edwards et al. · Scientific Reports · 2021 · 113 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Diagnostics +16

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies

Sophie I. Owen, Christopher T. Williams, Gala Garrod et al. · Journal of Infection · 2021 · 21 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15